Kalos Management’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-17,075	Closed	-$244K	–	44
2022 Q2	$244K	Sell	17,075 -1,150	-6%	-$21.5K	0.33%	102
2022 Q1	$441K	Sell	18,225 -1,464	-7%	-$35.4K	0.3%	75
2021 Q4	$340K	Buy	19,689 +1,114	+6%	+$22.4K	0.09%	207
2021 Q3	$321K	Sell	18,575 -100	-0.5%	-$1.93K	0.09%	210
2021 Q2	$433K	Hold	18,675	–	–	0.18%	149
2021 Q1	$460K	Sell	18,675 -275	-1%	-$12.1K	0.14%	164
2020 Q4	$1.01M	Sell	18,950 -500	-3%	-$24.8K	0.43%	74
2020 Q3	$812K	Buy	19,450 +100	+0.5%	+$4.32K	0.36%	84
2020 Q2	$935K	Buy	19,350 +3,600	+23%	+$173K	0.39%	83
2020 Q1	$672K	Sell	15,750 -3,000	-16%	-$124K	0.3%	93
2019 Q4	$795K	Hold	18,750	–	–	0.29%	101
2019 Q3	$680K	Hold	18,750	–	–	0.27%	105
2019 Q2	$501K	Buy	18,750 +4,829	+35%	+$123K	0.23%	111
2019 Q1	$373K	Sell	13,921 -6,129	-31%	-$143K	0.24%	99
2018 Q4	$420K	Buy	20,050 +800	+4%	+$15.5K	0.2%	113
2018 Q3	$392K	Buy	19,250 +1,400	+8%	+$22K	0.21%	110
2018 Q2	$416K	Hold	17,850	–	–	0.19%	132
2018 Q1	$416K	Sell	17,850 -800	-4%	-$22.1K	0.25%	94
2017 Q4	$558K	Buy	18,650 +3,500	+23%	+$112K	0.26%	106
2017 Q3	$570K	Buy	+15,150	New	+$493K	0.37%	83
2017 Q2	–	Sell	-10,600	Closed	-$364K	–	102
2017 Q1	$364K	Hold	10,600	–	–	0.26%	100
2016 Q4	$306K	Buy	10,600 +1,750	+20%	+$46.3K	0.25%	100
2016 Q3	$282K	Buy	8,850 +1,750	+25%	+$59.3K	0.24%	117
2016 Q2	$230K	Buy	+7,100	New	+$238K	0.18%	134